Search
for
Sort by
Research 241–270 of 774
- Repurposed Drugs: Current Trends in Drug Discovery
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- SnapshotDx Quiz: May 2020
- Therapeutic potential of Lawsonia inermis Linn: a comprehensive overview
- Immune-Epithelial Cross Talk in Regeneration and Repair
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Diagnostic, Therapeutic, and Theranostic Multifunctional Microneedles
- CD34 <sup>+</sup> cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Premature aging syndromes: From patients to mechanism
- Resident macrophages of the lung and liver: The guardians of our tissues
- Partial Proteasome Inhibitors Induce Hair Follicle Growth by Stabilizing β-Catenin
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- DNA Damage, Checkpoint Responses, and Cell Cycle Control in Aging Stem Cells
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Embryologic layers in dermatology: Developmental checkpoint disorders, diagnostic insight, and regenerative futures
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Transposon control as a checkpoint for tissue regeneration
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- 415 IL-17C: Checkpoint in innate skin immunology
- Author response: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma
- Decision letter: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma